MarketPulse
F

$FBLG

4 articles found
3 positive
0 negative
1 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Fibrobiologics, Inc.

FibroBiologics Advances Clinical Pipeline With cGMP Manufacturing, Raises $3M

FibroBiologics completes cGMP manufacturing for lead candidate CYWC628, expects first patient dosing Q2 2026 in diabetic foot ulcer trial. Company raises $3M and maintains $1.5M cash.
FBLGcapital raisepreclinical results
GlobeNewswire Inc.GlobeNewswire Inc.··Delveinsight

90+ Companies Racing to Transform Psoriasis Treatment Landscape

Over 90 pharmaceutical companies are advancing 100+ psoriasis drugs through clinical trials, with major players like Takeda and Alumis posting positive Phase III results.
SNGXTAKFBLGCANFALMS+1clinical trialsbiologics
GlobeNewswire Inc.GlobeNewswire Inc.··Fibrobiologics, Inc.

FibroBiologics Prices $3M Offering, Advances Diabetic Ulcer Drug

FibroBiologics prices $3M offering and validates manufacturing of CYWC628 for diabetic ulcer trials while restoring Nasdaq compliance.
FBLGclinical trialpublic offering
BenzingaBenzinga··Prnewswire

Cell Therapies Graduate to Mass Production as Market Eyes $8.2B Prize

Cell therapy companies achieve major manufacturing and clinical milestones, positioning sector for explosive growth as global market targets $8.2 billion by 2026.
MESOFATEFBLGLGVNbiotechclinical trials